Stocks News

LAST PRICE
48.4900
TODAY'S CHANGE (%)
Trending Down-0.2300 (-0.4721%)

Bid / Lots
48.5000/ 1
Ask / Lots
49.0000/ 2
Open / Previous Close
48.3200 / 48.7200
Day Range
Low 48.3000
High 48.6300
52 Week Range
Low 45.2200
High 58.9700
Volume
1,401,358
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8 hours ago by MT Newswires
  8 hours ago by MT Newswires
  Companies Mentioned: JNJ, MRK, SNY, ZLAB, AZN, BMY, BGNE
  08:09 AM EST, 11/29/2024 (MT Newswires) -- Astrazeneca (AZN) confirmed Friday in an emailed statement to MT Newswires that its breast cancer treatment Enhertu and cancer treatment Orpathys have been added to China's National Reimbursement Drug List ...
Nov 25, 2024
- DJ Sanofi's U.S. Hospital Drug-Discount Program Seems Positive But Rollout Hurdles Remain -- Market Talk, from 4:15AM ET on Monday Nov 25, 2024 by Dow Jones
  4:15AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: SNY
  
  0914 GMT - Sanofi's revised hospital drug-discount program in the U.S. holds long-term promise, although industry-wide implementation hurdles persist, Bryan Garnier Health analysts say in a note. The U.S. federal program, known as 340B and aimed at vulnerable patients, is increasingly used by hospitals to profit by charging the drugs' list prices while purchasing them at a discount, the analysts say. Under its new plan, Sanofi requires institutions to provide medical claims information before receiving discounts. Eli Lilly and Johnson & Johnson this month sued the federal government for rejecting similar rebate proposals. Sanofi reported in 2023 that discounts under Medicare and 340B led to a 15.7% decrease in its portfolio net price. Shares fall 0.3% to 92.89 euros. (helena.smolak@wsj.com)
Nov 22, 2024
- DJ Sanofi Plans to Change Hospital Drug-Discount Program -- 3rd Update, from 5:20PM ET on Friday Nov 22, 2024 by Dow Jones
  5:20PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: SNY
  
  By Jared S. Hopkins
  
  An industry fight against lucrative drug discounts for hospitals is intensifying as another drugmaker joins the battle: Sanofi.
  
  The pharmaceutical company plans to change its policy on how it gives discounts to certain hospitals. Sanofi will require institutions to provide pharmacy and medical claims information before receiving federally mandated discounts. The company sent a letter, which was viewed by The Wall Street Journal, to hospitals outlining its new model on Friday , according to people familiar with the matter.
- Market Chatter: Sanofi Plans Drug Discount Policy Restriction, from 12:27PM ET on Friday Nov 22, 2024 by MT Newswires
  12:27PM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: SNY
  12:27 PM EST, 11/22/2024 (MT Newswires) -- Sanofi (SNY) is planning to revise its policy regarding drug discounts for certain hospitals, The Wall Street Journal reported Friday, citing people familiar with the matter. Under the new policy, hospitals...
- DJ Sanofi Plans to Change Hospital Drug-Discount Program -- 2nd Update, from 11:39AM ET on Friday Nov 22, 2024 by Dow Jones
  11:39AM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: SNY
  
  By Jared S. Hopkins
  
  An industry fight against lucrative drug discounts for hospitals is intensifying as another drugmaker joins the battle: Sanofi.
  
  The pharmaceutical company plans to change its policy on how it gives discounts to certain hospitals. Sanofi will require institutions to provide pharmacy and medical claims information before receiving federally mandated discounts. The company plans to send a letter, which was reviewed by The Wall Street Journal, to hospitals outlining its new model on Friday , according to people familiar with the matter.

Today
- DJ AstraZeneca PLC Stock Falls Friday, Underperforms Market, from 4 hours ago by Dow Jones
  4 hours ago by Dow Jones
  Companies Mentioned: AZN
- Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8 hours ago by MT Newswires
  8 hours ago by MT Newswires
  Companies Mentioned: JNJ, MRK, SNY, ZLAB, AZN, BMY, BGNE
- AZN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AstraZeneca PLC, from 8 hours ago by Accesswire
  8 hours ago by Accesswire
  Companies Mentioned: AZN
- AZN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AstraZeneca PLC, from 8 hours ago by Dow Jones
  8 hours ago by Dow Jones
  Companies Mentioned: AZN
- Berenberg Adjusts Price Target on Pfizer to $29 From $27, Maintains Hold Rating, from 10 hours ago by MT Newswires
  10 hours ago by MT Newswires
  Companies Mentioned: PFE
Yesterday
- DJ AstraZeneca PLC Stock Rises Thursday, Outperforms Market, from 12:01PM ET on Thursday Nov 28, 2024 by Dow Jones
  12:01PM ET on Thursday Nov 28, 2024 by Dow Jones
  Companies Mentioned: AZN
Nov 27, 2024
- AZN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your AstraZeneca PLC investment, from 12:16PM ET on Wednesday Nov 27, 2024 by Accesswire
  12:16PM ET on Wednesday Nov 27, 2024 by Accesswire
  Companies Mentioned: AZN
- AZN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your AstraZeneca PLC investment, from 12:16PM ET on Wednesday Nov 27, 2024 by Dow Jones
  12:16PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: AZN
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN, from 12:02PM ET on Wednesday Nov 27, 2024 by Accesswire
  12:02PM ET on Wednesday Nov 27, 2024 by Accesswire
  Companies Mentioned: AZN
- DJ AstraZeneca PLC Stock Rises Wednesday, Outperforms Market, from 12:01PM ET on Wednesday Nov 27, 2024 by Dow Jones
  12:01PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: AZN

Sanofi SA
NASDAQ:SNYUnited States

Search Criteria

Today

Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8 hours ago by MT Newswires

Nov 25, 2024

DJ Sanofi's U.S. Hospital Drug-Discount Program Seems Positive But Rollout Hurdles Remain -- Market Talk, from 4:15AM ET on Monday Nov 25, 2024 by Dow Jones

Nov 22, 2024

DJ Sanofi Plans to Change Hospital Drug-Discount Program -- 3rd Update, from 5:20PM ET on Friday Nov 22, 2024 by Dow Jones

Market Chatter: Sanofi Plans Drug Discount Policy Restriction, from 12:27PM ET on Friday Nov 22, 2024 by MT Newswires

DJ Sanofi Plans to Change Hospital Drug-Discount Program -- 2nd Update, from 11:39AM ET on Friday Nov 22, 2024 by Dow Jones

Peers Headlines

Today

DJ AstraZeneca PLC Stock Falls Friday, Underperforms Market, from 4 hours ago by Dow Jones

Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8 hours ago by MT Newswires

AZN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AstraZeneca PLC, from 8 hours ago by Accesswire

AZN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AstraZeneca PLC, from 8 hours ago by Dow Jones

Berenberg Adjusts Price Target on Pfizer to $29 From $27, Maintains Hold Rating, from 10 hours ago by MT Newswires

Yesterday

DJ AstraZeneca PLC Stock Rises Thursday, Outperforms Market, from 12:01PM ET on Thursday Nov 28, 2024 by Dow Jones

Nov 27, 2024

AZN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your AstraZeneca PLC investment, from 12:16PM ET on Wednesday Nov 27, 2024 by Accesswire

AZN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your AstraZeneca PLC investment, from 12:16PM ET on Wednesday Nov 27, 2024 by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN, from 12:02PM ET on Wednesday Nov 27, 2024 by Accesswire

DJ AstraZeneca PLC Stock Rises Wednesday, Outperforms Market, from 12:01PM ET on Wednesday Nov 27, 2024 by Dow Jones